nach oben

Internal and Emergency Medicine

Erschienen in:

22.05.2017 | IM - COMMENTARY

Claims-based or clinical models for predicting 90-day post-pulmonary embolism outcomes

verfasst von: Cecilia Becattini, Giancarlo Agnelli

Erschienen in: Internal and Emergency Medicine | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Excerpt

The clinical presentation of pulmonary embolism is remarkably variable. The features of clinical presentation may be used to predict the short-term clinical outcome of patients with pulmonary embolism [1, 2]. Based on clinical presentation, patients’ features and presence/absence of right ventricle overload, at least three risk categories of patients with acute pulmonary embolism at expected low, intermediate or high risk for short-term death can be identified [3]. The final aim of risk stratification is to tailor treatment and patients’ management according to the expected risk for death [4]. …

Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389CrossRefPubMed

Casazza F, Becattini C, Bongarzoni A, Cuccia C, Roncon L, Favretto G, Zonzin P, Pignataro L, Agnelli G (2012) Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). Thromb Res 130:847–852CrossRefPubMed

Becattini C, Agnelli G, Lankeit M, Masotti L, Pruszczyk P, Casazza F, Vanni S, Nitti C, Kamphuisen P, Vedovati MC, De Natale MG, Konstantinides S (2016) Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J 48:780–786CrossRefPubMed

Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Authors/Task Force Members (2014) ESC guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014(35):3033–3069

Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI (2017) External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Intern Emerg Med. doi:10.1007/s11739-017-1625-9 PubMed

Guercini F, Mommi V, Camporese G, Tonello C, Imberti D, Benedetti R, De Bartolomeo G, Di Lecce L, Romeo F, Agnelli G (2016) The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registry. Intern Emerg Med 11:1095–1102CrossRefPubMed

Elias A, Mallett S, Daoud-Elias M, Poggi JN, Clarke M (2016) Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open 6:e010324CrossRefPubMedPubMedCentral

Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172:1041–1046CrossRefPubMedPubMedCentral

Jimenez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389CrossRefPubMed

10.

Venetz C, Jiménez D, Mean M, Aujesky D (2011) A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost 106:423–428CrossRefPubMed

11.

Polo Friz H, Molteni M, Del Sorbo D, Pasciuti L, Crippa M, Villa G, Meloni DF, Primitz L, Galli A, Rognoni M, Cavalieri d’Oro L, Arpaia G, Cimminiello C (2015) Mortality at 30 and 90 days in elderly patients with pulmonary embolism: a retrospective cohort study. Intern Emerg Med 10:431–436CrossRefPubMed

12.

Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, Sanchez O, Pugh NA, N’gako A, Cornuz J, Hugli O, Beer HJ, Perrier A, Fine MJ, Yealy DM (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378:41–48CrossRefPubMed

13.

Maestre A, Trujillo-Santos J, Riera-Mestre A, Jiménez D, Di Micco P, Bascuñana J, Vela JR, Peris L, Malfante PC, Monreal M; RIETE Investigators (2015) Identification of low-risk patients with acute symptomatic pulmonary embolism for outpatient therapy. Ann Am Thorac Soc 12:1122–1129

14.

Zondag W, Mos IC, Creemers-Schild D, Hoogerbrugge AD, Dekkers OM, Dolsma J, Eijsvogel M, Faber LM, Hofstee HM, Hovens MM, Jonkers GJ, van Kralingen KW, Kruip MJ, de Vlasveld T, Vreede MJ, Huisman MV, Hestia Study Investigators (2011) Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 9:1500–1507CrossRefPubMed

15.

den Exter PL, Zondag W, Klok FA, Brouwer RE, Dolsma J, Eijsvogel M, Faber LM, van Gerwen M, Grootenboers MJ, Heller-Baan R, Hovens MM, Jonkers GJ, van Kralingen KW, Melissant CF, Peltenburg H, Post JP, van de Ree MA, de Vlasveld LT, Vreede MJ, Huisman MV, Vesta Study Investigators (2016) Efficacy and safety of outpatient treatment based on the hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial. Am J Respir Crit Care Med 194:998–1006CrossRef

16.

Weeda ER, Kohn CG, Fermann GJ, Peacock WF, Tanner C, McGrath D, Crivera C, Schein JR, Coleman CI (2016) External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches. Thromb J 14:7CrossRefPubMedPubMedCentral

17.

Søgaard KK, Schmidt M, Pedersen L, Horváth-Puhó E, Sørensen HT (2014) 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation 130:829–836CrossRefPubMed

18.

Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA (2009) Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest 136:983–990CrossRefPubMed

19.

Dentali F, Di Minno MN, Gianni M, Ambrosino P, Squizzato A, Ageno W (2015) Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med 10:507–514CrossRefPubMed

20.

Becattini C, Agnelli G (2015) Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? No. Intern Emerg Med 10:281–284CrossRefPubMed

21.

Meyer G, Sanchez O, Planquette B (2015) Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? Yes. Intern Emerg Med 10:277–280CrossRefPubMed

Titel: Claims-based or clinical models for predicting 90-day post-pulmonary embolism outcomes
verfasst von: Cecilia Becattini
Giancarlo Agnelli
Publikationsdatum: 22.05.2017
Verlag: Springer International Publishing
Erschienen in: Internal and Emergency Medicine / Ausgabe 5/2017
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-017-1676-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Claims-based or clinical models for predicting 90-day post-pulmonary embolism outcomes

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2017

Association between rheumatic diseases and cancer: results from a clinical practice cohort study

Emergencies in motoneuron disease

A unique pneumopathy in a patient with skin nodules and abscesses

Guidelines on the management of atrial fibrillation in the emergency department: a critical appraisal

Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit

Unplanned hospital admissions of palliative care patients: a great challenge for internal and emergency medicine physicians

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin